Confrontation, passion, and personalization

Clinical Cancer Research

Volumn 3, Issue 12 II, 1997, Pages 2554-2562

  Frei III, Emil ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ART; ARTICLE; HISTORY; HUMAN; HUNGARY; LEUKEMIA; NEOPLASM; ONCOLOGY; UNITED STATES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HISTORY, 20TH CENTURY; HUMANS; HUNGARY; LEUKEMIA; MEDICAL ONCOLOGY; NEOPLASMS; PORTRAITS; UNITED STATES;

EID: 0031292083     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Frei, E., III, Holland, J. F., Schneiderman, M. A., Pinkel, D., Selkirk, G., Freireich, E. J, Silver, R. T., Gold, G. L., and Regelson, W. A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood, 13: 1126-1148, 1958.
2. Zubrod, C. G., Schneiderman, M. A., Frei, E., III, Brindley, C., Gold, G. L., Shnider, B., Oviedo, R., Gorman, J., Jones, R., Jr., Jonsson, U., Colsky, J., Chalmers, T., Ferguson, B., Dederick, M., Holland, J., Selawry, O., Regelson, W., Lasagna, L., and Owens, A. H., Jr. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J. Chronic Dis., 11: 7-33, 1960.
3. Freireich, E. J, Gehan, E., Sulman, D., Boggs, D. R., and Frei, E., III. The effect of chemotherapy on acute leukemia in the human. J. Chronic Dis., 14: 593-608, 1961.
4. Frei, E., III, Freireich, E. J, Gehan, E., Pinkel, D., Holland, J. F., Selawry, O., Haurani, F., Spurr, C. L., Hayes, D. M., James, G. W., Rothberg, H., Sodee, D. B., Rundles, R. W., Shroeder, L. R., Hoogstraten, B., Wolman, I. J., Traggis, D. G., Cooper, T., Gendel, B. R., Ebaugh, F., and Taylor, R. Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood, 18: 431-454, 1961.
5. Frei, E., III. Combination cancer therapy: presidential address. Cancer Res., 32: 2593-2607, 1972.
6. Frei, E., III, and Freireich, E. J. Progress and perspectives in the chemotherapy of acute leukemia. Adv. Chemother., 2: 269-289, 1965.
7. Freireich, E. J, Gehan, E., Frei, E., III, Schroeder, L. R., Wolman, I. J., Anbari, R., Burgert, E. O., Mills, S. D., Pinkel, D., Selawry, O. S., Moon, J. H., Gendel, B. R., Spurr, C. L., Storrs, R., Haurani, F., Hoogstraten, B., and Lee, S. The effect of 6-mercaptopurine on the duration of steroid-induced remissions in acute leukemia: a model for evaluation of other potentially useful therapy. Blood, 21: 699-716, 1963.
8. Skipper, H. E. Adjuvant chemotherapy. Cancer (Phila.), 41: 936-940, 1978.
9. Skipper, H. E., Schabel, F., and Wilcox, W. Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosyl cytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother. Rep., 51: 125, 1976.
10. Gribben, J. G., Neuberg, D. N., Barber, M., Moore, J., Pesek, K. W., Freedman, A. S., and Nadler, L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in the bone marrow. Blood, 83: 3800-3807, 1994.
11. Roberts, W. M., Zeev, E., Ouspenskaia, M. V., Johnston, D. A., McClain, K. L., and Zipf, T. F. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N. Engl. J. Med., 336: 317-323, 1997.
12. Pinkel, D., Hernandez, K., Borella, L., Holton, C., Aur, R., Samoy, G., and Pratt, C. Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer (Phila.), 27: 247-256, 1971.
13. Holland, J. F. E pluribus unum: presidential address. Cancer Res., 31: 1319-1329, 1971.
14. Holland, J. F. Breaking the cure barrier. Karnofsky Memorial Lecture. J. Clin. Oncol., 1: 75-90, 1983.
15. Selawry, O. S., Hananian, J., Wolman, I. J., et al. (Acute Leukemia Group B). New treatment schedule with improved survival in childhood leukemia. J. Am. Med. Assoc., 194: 75-81, 1965.
16. Schimpke, R. T., Sherweed, S., Johnston, R., Hill, A., Rice, G., Hoy, C., Feder, J., and Farnham, P. On the mechanism of induced gene amplification in mammalian cells. In: P. V. Woolley III and K. D. Tew (eds.). Mechanisms of Drug Resistance in Neoplastic Cells, p. 29. San Diego: Academic Press, 1988.
17. Pinkel, D. The Ninth Annual David Karnofsky Lecture: treatment of acute lymphocytic leukemia. Cancer (Phila.), 48: 1128-1137, 1979.
18. Aur, R. J. A., Simone, J. V., Hustu, H. O., Walters, T., Borella, L., Pratt, C., and Pinkel, D. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood, 37: 272-281, 1971.
19. Reiter, A., Schrappe, M., Ludwig, W-D., Hiddemann, W., Siegfried, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., Niethammer, D., Odenwald, E., Ritter, J., Mann, G., Weite, K., Gadner, H., and Riehm, H. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood, 84: 3122, 1994.
20. Schorin, M. A., Blattner, S., Gelber, R. D., Tarbell, N. J., Donnelly, M., Dalton, V., Cohen, H. J., and Sallan, S. E. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/ Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J. Clin. Oncol., 12: 740-747, 1994.
21. Hester, J. Hematopoietic supportive care. J. Clin. Cancer Res., 3: 2666-2670, 1997.
22. Freireich, E., Schmidt, P. J., Schneiderman, M. A., and Frei, E., III. A comparative study of the effect of transfusion of fresh and preserved whole blood on bleeding in patients with acute leukemia. N. Engl. J. Med., 260: 6-11, 1959.
23. Gaydos, L. A., Freireich, E., and Mantel, N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N. Engl. J. Med., 266: 905-909, 1962.
24. Hersh, E. M., Bodey, G. P., Nies, B. A., and Freireich, E. I. Causes of death in acute leukemia: a 10-year study of 414 patients. J. Am. Med. Assoc., 193: 105-109, 1965.
25. Freireich, E., Levin, R. H., Whang, J., Carbone, P. P., Bronson, W., and Morse, E. E. The function and fate of transfused leukocytes from donors with chronic myelogenous leukemia in leukopenic recipients. Ann. N. Y. Acad. Sci., 113: 1081-1089, 1964.
26. Freireich, E. J, Morse, E. F., Bronson, W., and Carbone, P. P. Transfusion of (a) granulocytes from donors with chronic myelocytic leukemia to leukopenic recipients. In: Proceedings of the IXth Congress of the International Society of Hematology, Vol. 1, pp. 549-557, 1962.
27. Levin, R. H., Whang, J., Carbone, P. P., and Freireich, E. J. Erythroid hemografts following leukocyte transfusion in a patient with acute leukemia. Blood, 26: 587-609, 1965.
28. Freireich, E. J. Continuous flow in vivo blood cell separator. Lab. Manage., 6: 20-23, 43-48, 1968.
29. Freireich, E. J, Henderson, E. S., Karon, M., and Frei, E., III. The treatment of acute leukemia considered with respect to cell population kinetics. In: Proliferation and Spread of Neoplastic Cells: The University of Texas M. D. Anderson Cancer Center, 21st Annual Symposium on Fundamental Cancer Research, pp. 441-453. Baltimore: Williams and Wilkins Co., 1968.
30. Freireich, E. J, Karon, M., and Frei, E., III. Combination chemotherapy of childhood leukemia with vincristine, amethopterin, mercaptopurine and prednisone (VAMP). Proc. Am. Assoc. Cancer Res., 5: 50, 1964.
31. Henderson, E. S. Combination chemotherapy of acute lymphocytic leukemia of childhood. Cancer Res., 27: 2570-2572, 1967.
32. Frei, E., III, DeVita, V. T., Moxley, J. H., III, and Carbone, P. P. Approaches to improving the chemotherapy of Hodgkin's disease. Cancer Res., 26: 1284-1289, 1966.
33. DeVita, V. T., Serpik, A., and Carbone, P. P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann. Intern. Med., 73: 881, 1970.
34. Shnider, B. I., Baig, M., Serpick, A., and Kayhoe, D. E. Combination therapy with 5-fluorouracil, cyclophosphamide, vincrinstine and methotrexate. J. Clin. Pharmacol., 15: 69-73, 1975.
35. Bronowski, J. The creative process. Sci. Am., 199: 5-11, 1958.
36. Freireich, E. J. The future of clinical cancer research in the next millenium. Clin. Cancer Res., 3: 2563-2570, 1997.